UK Markets open in 1 hr.

Achillion Pharmaceuticals, Inc. (ADA.F)


Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.66-0.12 (-3.12%)
As of 3:35PM CEST. Market open.
Interactive chart
Previous close3.78
Open3.62
Bid3.62 x 43600
Ask3.77 x 42000
Day's range3.62 - 3.66
52-week range2.89 - 8.24
Volume400
Avg. volume854
Market cap500.41M
BetaN/A
PE ratio (TTM)-7.84
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Why Achillion Pharmaceuticals Stock Is Jumping 15% Today
    Motley Fool5 days ago

    Why Achillion Pharmaceuticals Stock Is Jumping 15% Today

    One Wall Street analyst is warming up to this clinical-stage biotech, and that's sparking a rally.

  • Barrons.com6 days ago

    Achillion: It Can't Get Any Worse…Or Can It?

    Does Achillion Pharmaceuticals (ACHN) have any upside ahead? In a note published today, Leerink analyst Joseph Schwartz upgraded the beaten-down biotech stock to Outperform and lifted his price target to $6 a share, arguing that there is limited downside at current levels even if its foray outside the hepatitis C market continues to hit snags. At the current stock price, we believe that there is limited downside for investors even if complement fails, assuming the HCV partnership remains intact.

  • Achillion (ACHN) Reports Wider-than-Expected Loss in Q1
    Zacks15 days ago

    Achillion (ACHN) Reports Wider-than-Expected Loss in Q1

    Achillion Pharmaceuticals, Inc. (ACHN) reported a loss of 15 cents per share in the first quarter, wider than the Zacks Consensus Estimate of a loss of 8 cents. In the year-ago quarter, the company had reported a loss of 13 cents per share.